Karyopharm Therapeutics (KPTI) Q3 2025 Earnings

Aug 11Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-4.42
-3.03
-1.65
-0.26

Details

Expected EPS
-4.081667
Actual EPS
-4.32
Surprise EPS
-0.24
Surprise Percent
-5.84%

Description

⁨Karyopharm Therapeutics⁩ (⁦KPTI⁩) has reported earnings of ⁦-4.32⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts